SARS CoV 2 News and Research

RSS

On Trump’s last full day, nation records 400,000 covid deaths

While millions wait for a lifesaving shot, the U.S. death count from covid-19 continues to soar upward with horrifying speed.

19 Jan 2021

Memory B cell response to SARS-CoV-2 evolves up to 6 months after infection, study finds

A new study shows that the memory B cell response to SARS-Cov-2 evolves between 1.3 and 6.2 months after infection in a manner that is consistent with antigen persistence.

19 Jan 2021

Which SARS-CoV-2 mutations can potentially evade antibody recognition?

A team of US-based researchers has systematically identified SARS-CoV-2 mutations that could potentially evade neutralizing antibodies produced by the current vaccine candidates.

19 Jan 2021

Study predicts good passive immunotherapy donors to combat COVID-19

A US-based research team determine good candidates for convalescent plasma donations in promoting passive immunity among severely-ill COVID-19 patients.

19 Jan 2021

New coronavirus strain found in more than one-third of COVID-19 cases in Los Angeles

A new strain of the coronavirus has been found in more than one-third of COVID-19 cases in Los Angeles and may be contributing to the acceleration of the recent surge of cases across Southern California, according to new research from Cedars-Sinai.

19 Jan 2021

RECoVERY: New open-source software developed for analyzing SARS-CoV-2 genomes

Researchers report an open-source platform-independent tool for building SARS-CoV-2 genomes from raw sequencing reads. The tool can be used without any extra hardware or software and be run using any browser from a desktop or mobile.

19 Jan 2021

Kruppel-like factor 2 may be a major determinant of acute respiratory distress syndrome in COVID-19 patients

A study conducted at the University of Chicago, USA, has recently revealed that downregulation of an endothelial transcription factor, Kruppel-like factor 2, by SARS-CoV-2 is responsible for ARDS frequently observed in critically ill COVID-19 patients.

19 Jan 2021

Lower CD4 T cell reactivity to seasonal coronaviruses found in healthcare workers with COVID-19

A new study by US-based researchers describes the results of a study on the immune response among healthcare workers, in particular, their T cell responses predating the pandemic.

19 Jan 2021

Large study finds SARS-CoV-2 viral load is lowest in children

A new study by researchers in the Netherlands confirms the hypothesis that for SARS-CoV-2 infection, higher age is associated with increased viral loads.

19 Jan 2021

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

A new study by researchers at Northwestern University Feinberg School of Medicine, USA, shows that antibiotic regimens for critically ill COVID-19 patients with bacterial superinfections may be promoting an unnecessarily high.

19 Jan 2021

Viral genome sequencing of wastewater can be useful for tracking new SARS-CoV-2 variants

Viral genome sequencing of wastewater can detect new SARS-CoV-2 variants before they are detected by local clinical sequencing, according to a new study reported in mBio, an open-access journal of the American Society for Microbiology.

19 Jan 2021

Early administration of ivermectin could help reduce viral transmission in COVID-19 patients

A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission.

19 Jan 2021

N501Y mutation may be associated with higher viral load, says preliminary study

A new preprint research paper posted to the medRxiv server deals with the preliminary results of a study on the so-called British variant, UI-202012/01, also known as lineage B.1.1.7 or 20B/501Y.V1.

19 Jan 2021

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

An interesting new preprint published on the medRxiv server describes an immunosuppressed patient with coronavirus disease 2019 (COVID-19) who continued to shed the virus for an astounding 154 days. During this period, the virus underwent numerous mutations.

19 Jan 2021

Scientists set research priorities for COVID-19 vaccines

More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the World Health Organization (WHO) to identify knowledge gaps and set research priorities for vaccines against SARS-CoV-2, the virus that causes COVID-19.

19 Jan 2021

WHO Emergency Committee to review emerging SARS-CoV-2 variants

The COVID-19 pandemic continues to constitute a Public Health Emergency of International Concern (PHEIC), according to the WHO Emergency Committee (EC) on COVID-19.

19 Jan 2021

Global scientists are intensifying research on COVID-19

Global scientists are intensifying research into COVID-19, as the World Health Organization (WHO) moves to expand its scientific collaboration and monitoring of emerging variants of SARS-CoV-2, the virus that causes COVID-19.

18 Jan 2021

Genomics reveals distinct patterns of emergence of SARS‐CoV‐2 spike variants in Columbus, Ohio

Recently researchers from the United States reported the results of a SARS‐CoV‐2 genomic surveillance conducted between April 2020 and January 2021 in Columbus, Ohio. Their work is released as a preprint on the bioRxiv server.

18 Jan 2021

Understanding the Philippines' relative success with COVID-19

Many high-income countries have reported rising numbers of cases, while a few low-income countries such as the Philippines report a less severe COVID-19 outbreak. To date, the archipelagic country in Southeast Asia has reported 502,000 cases and 9,900 deaths among its population of around 108 million.

18 Jan 2021

About 60 percent of SARS-CoV-2 cases in England tied to new variant by the end of December

One new SARS-CoV-2 variant of concern, called 202012/01, started to spread in England in late October. A new study published on the pre-print server medRxiv found that 60 percent of daily COVID-19 cases screened by the Alderley Park Lighthouse Labs were tied to 202012/01, also known as lineage B.1.1.7 or 20B/501Y.V1. This suggests a rapid spread of the new variant across the country.

18 Jan 2021

SARS CoV 2 News and Research

On Trump’s last full day, nation records 400,000 covid deaths

Memory B cell response to SARS-CoV-2 evolves up to 6 months after infection, study finds

Which SARS-CoV-2 mutations can potentially evade antibody recognition?

Study predicts good passive immunotherapy donors to combat COVID-19

New coronavirus strain found in more than one-third of COVID-19 cases in Los Angeles

RECoVERY: New open-source software developed for analyzing SARS-CoV-2 genomes

Kruppel-like factor 2 may be a major determinant of acute respiratory distress syndrome in COVID-19 patients

Lower CD4 T cell reactivity to seasonal coronaviruses found in healthcare workers with COVID-19

Large study finds SARS-CoV-2 viral load is lowest in children

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

Viral genome sequencing of wastewater can be useful for tracking new SARS-CoV-2 variants

Early administration of ivermectin could help reduce viral transmission in COVID-19 patients

N501Y mutation may be associated with higher viral load, says preliminary study

Prolonged shedding and multiple mutations 154 days after initial SARS-CoV-2 diagnosis reported

Scientists set research priorities for COVID-19 vaccines

WHO Emergency Committee to review emerging SARS-CoV-2 variants

Global scientists are intensifying research on COVID-19

Genomics reveals distinct patterns of emergence of SARS‐CoV‐2 spike variants in Columbus, Ohio

Understanding the Philippines' relative success with COVID-19

About 60 percent of SARS-CoV-2 cases in England tied to new variant by the end of December

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News